Detalhe da pesquisa
1.
Exagamglogene Autotemcel for Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 390(18): 1663-1676, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657265
2.
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
N Engl J Med
; 390(18): 1649-1662, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661449
3.
Whole-blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise.
Br J Haematol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768976
4.
Reference Values for Cardiorespiratory Fitness in Patients Aged 6 to 18 Years.
J Pediatr
; 264: 113770, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802386
5.
Return visit rates after an emergency department discharge for children with sickle cell pain episodes.
Pediatr Blood Cancer
; 70(10): e30553, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458568
6.
Development of a Pediatric Cardiology Cardiopulmonary Exercise Testing Database.
Pediatr Cardiol
; 2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757429
7.
Emergency department visits and hospitalizations among patients with sickle cell disease in illinois, 2016-2020.
Pediatr Hematol Oncol
; 40(1): 70-75, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612367
8.
Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
Br J Haematol
; 196(2): 397-401, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549417
9.
Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
Br J Haematol
; 196(1): 179-182, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312843
10.
Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia.
Pediatr Blood Cancer
; 69(6): e29607, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373884
11.
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years.
Pediatr Blood Cancer
; 69(8): e29716, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451176
12.
Safety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review.
Br J Sports Med
; 56(13): 764-769, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285054
13.
Digital behavioural interventions for people with sickle cell disease.
Cochrane Database Syst Rev
; 2021(4)2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650329
14.
Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
Pediatr Blood Cancer
; 67(5): e28152, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147964
15.
Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA.
Blood
; 129(6): 723-728, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856464
16.
Nucleated Red Blood Cells in Children With Sickle Cell Disease Hospitalized for Pain.
J Pediatr Hematol Oncol
; 41(8): e487-e492, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951023
17.
Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit-A Case Control Study.
J Pediatr
; 195: 28-32, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398052
18.
Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD).
Eur J Haematol
; 101(4): 532-541, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29999202
19.
Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease.
Pediatr Hematol Oncol
; 35(5-6): 297-308, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636474
20.
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.
Blood
; 126(14): 1651-7, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232172